- Price
- $27.87
- Day
- +1.42%
- Mkt Cap
- $6.66B
- 52W Range
- $8.11 – $28.22
- Volume
- 3.23M
- Beta
- 1.08
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered travel and expense management platform, today announced it has been selected by Insight Enterprises (NASDAQ: NSIT), a leading Solutions Integrator that helps clients solve technology challenges by combining the right hardware, software, and services, as its partner for unified travel and expense management. By moving to Navan's integrated platform, Insight is positioned to capture massive efficiencies across its ent.
Read full article
PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today introduced its most granular set of policy controls yet. This next evolution of its policy and approval engine gives global enterprises precise financial control while providing travelers with even clearer choices. Navan popularized dynamic travel policy in corporate travel, replacing rigid price caps with real-time, market-aware spending limits. These enhanced controls bu.
Read full article
[url="]Navan[/url] (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today introduced its most granular set of policy controls yet. Th
Read full article
Ann Berry is joined by Ariel Cohen, Co-Founder and CEO of Navan, to discuss how the company is modernizing business travel, leveraging AI to improve the traveler experience, and pursuing acquisitions to support its global expansion.
Read full article
PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. A life science company that is pioneering the future of drug discovery and development, Evotec had historically managed T&E independentl.
Read full article
[url="]Navan[/url] (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that [url="]Evotec[/url] (NASDAQ: EVO; Frankfurt
Read full article
NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Navan, Inc. (NASDAQ: NAVN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Navan, Inc. misrepresented its growth and revenue opportunities to investors by emphasizing in its Offering Documents that: (i) it had experienced rapid growth and that the Company offered solutions to customers of all sizes across all industries; and (ii) as a result, the Company's revenue increased 33% year-over-year from 2024 to 2025, its Gross Booking Volume increased 32% year-over-year from 2024 to 2025, and its usage yield was approximately 7% in both 2024 and 2025.
Read full article
Navan earns a buy rating due to its deeply embedded, all-in-one business travel and expense platform, driving strong customer retention. NAVN's long growth runway is supported by multi-year customer ramping, expanding product adoption, and increasing enterprise wins, evidenced by 45 S&P 500 customers in Q1 2027. AI-driven automation, especially the Ava assistant, is significantly reducing support costs and expanding gross margins, reaching 75% in Q1 2027.
Read full article